drugset / Trial / NCT01216605

Oxytocin and Emotion Recognition

NCT01216605

Phase 4 Completed 56 enrolled University Hospital Freiburg
RandomizedParallel-groupTriple-blindBasic science

Summary

The present study was designed to investigate the effects of a single dose of synthetic oxytocin on facial emotion recognition in healthy adult man. Pictures of emotional faces are presented very briefly for a few milliseconds in a backward-masking paradigm in order to vary the level of awareness. In a randomized placebo-controlled between-subject design, recognition performance is compared between a drug (24 IU oxytocin) and a placebo condition. We hypothesize that oxytocin enhances emotion recognition even for facial stimuli processed with limited awareness.

Timeline

Start
2009-11
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 24 iu

Indications

No indication recorded.